HBME-1 expression by thyroid neoplasms in a Nigerian tertiary health Centre
Aim: The aim of this study is to review the histopathological diagnosis of thyroid neoplasms seen in OAUTHC Ile Ife using HBME-1 immunohistochemical marker. Materials and methods: We studied all thyroid neoplasms diagnosed in the Department of Morbid Anatomy and Forensic Medicine OAUTHC, Ile-Ife...
Main Authors: | Soremekun AI, Olaofe OO, Komolafe AO |
---|---|
Format: | Article |
Language: | English |
Published: |
Nigerian Medical Association, Akwa Ibom State Branch
2023-09-01
|
Series: | Ibom Medical Journal |
Subjects: | |
Online Access: | https://ibommedicaljournal.org/index.php/imjhome/article/view/355 |
Similar Items
-
The Utility of Galectin-3 and HBME-1 Immunohistochemical Expression in Thyroid Cancer in the Maltese Population
by: Christine Vella, et al.
Published: (2022-05-01) -
CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroid carcinoma and nodular thyroid lesions
by: Senay Erdogan-Durmus, et al.
Published: (2016-01-01) -
"MONOCLONAL ANTIBODY HBME-1 USEFULNESS IN DIFFERENTIATION OF BENIGN NEOPLASM AND DIFFERENTIATED THYROID CARCINOMA"
by: M. Mokhtari, et al.
Published: (2005-05-01) -
"MONOCLONAL ANTIBODY HBME-1 USEFULNESS IN DIFFERENTIATION OF BENIGN NEOPLASM AND DIFFERENTIATED THYROID CARCINOMA"
by: M. Mokhtari, et al.
Published: (2005-04-01) -
Diagnostic role of immunohistochemical markers CK19 and CD56 in thyroid neoplasms
by: Pallavi Priyadarshini, et al.
Published: (2023-01-01)